| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 1-Yr Return |
|---|---|---|---|---|---|
|
ICCM
Icecure Medical
|
Jun 17, 2026 | BUY |
Strong Buy
+976.6% avg upside
5 analysts
|
$73.50
1789.38% Upside
|
· |
|
RNTX
Rein Therapeutics
|
Jan 21, 2026 | HOLD |
Hold
+969.0% avg upside
5 analysts
|
— | -13.2% |
|
LSTA
Lisata Therapeutics
|
Jan 21, 2026 | HOLD |
Buy
+300.3% avg upside
11 analysts
|
— | -23.6% |
|
VRCA
Verrica Pharmaceuticals
|
Dec 17, 2025 | BUY |
Strong Buy
+181.8% avg upside
8 analysts
|
$17.00
160.40% Upside
|
-18.9% |
|
MNPR
Monopar Therapeutics Inc
|
Sep 25, 2025 | BUY |
Strong Buy
-4.9% avg upside
18 analysts
|
$93.00
11.06% Downside
|
-23.5% |
|
IBIO
Ibio
|
Sep 05, 2025 | BUY |
Strong Buy
+283.1% avg upside
11 analysts
|
$1.60
5.94% Upside
|
+75.0% |
|
BIOX
Bioceres Crop Solutions
|
Aug 22, 2025 | HOLD |
Buy
+3610.4% avg upside
5 analysts
|
$26.00
7647.41% Upside
|
-87.7% |
|
DARE
Daré Bioscience
|
Aug 18, 2025 | BUY |
Strong Buy
+547.7% avg upside
14 analysts
|
$11.00
431.49% Upside
|
-0.5% |
|
RADX
Radiopharm Theranostics Limited Sponsored ADR
|
Jul 21, 2025 | BUY |
Strong Buy
+327.7% avg upside
6 analysts
|
$18.00
320.54% Upside
|
+9.7% |
|
CADL
Candel Therapeutics
|
Jul 09, 2025 | BUY |
Strong Buy
+78.7% avg upside
10 analysts
|
$25.00
152.79% Upside
|
+61.4% |
|
CATX
Perspective Therapeutics
|
Mar 10, 2025 | BUY |
Strong Buy
+253.7% avg upside
22 analysts
|
$11.00
246.98% Upside
|
+110.6% |
|
HYPD
Hyperion DeFi
|
Nov 15, 2024 | HOLD |
Buy
+173.3% avg upside
8 analysts
|
— | · |
|
ADIL
Adial Pharmaceuticals
|
Feb 14, 2024 | BUY |
Strong Buy
+1715.0% avg upside
6 analysts
|
$26.00
828.51% Upside
|
-35.1% |
|
OTLK
Outlook Therapeutics
|
Jan 24, 2024 | BUY |
Buy
+426.0% avg upside
11 analysts
|
$31.40
1769.09% Upside
|
-75.1% |
|
BGMS
Bio Green Med Solution
|
Dec 19, 2023 | HOLD |
Buy
+1367.8% avg upside
7 analysts
|
— | -90.2% |
|
HEPA
Hepion Pharmaceuticals
|
Dec 07, 2023 | HOLD |
Strong Buy
+70409.5% avg upside
9 analysts
|
— | · |
|
LNTH
Lantheus
|
Nov 30, 2023 | BUY |
Strong Buy
-27.4% avg upside
20 analysts
|
$100.00
5.62% Downside
|
+24.6% |
|
GNLX
Genelux Corp.
|
Oct 31, 2023 | BUY |
Strong Buy
+508.8% avg upside
7 analysts
|
$30.00
906.75% Upside
|
-77.8% |
|
PROCF
Procaps Group
|
Sep 05, 2023 | HOLD |
Hold
+17828.3% avg upside
1 analyst
|
$4.50
17828.29% Upside
|
· |
|
ECOR
Electrocore
|
Jul 11, 2023 | BUY |
Buy
+580.6% avg upside
10 analysts
|
$23.00
246.33% Upside
|
+23.2% |
|
NOVN
Novan
|
Jun 14, 2023 | HOLD |
Buy
6 analysts
|
— | · |
|
NMTRQ
9 Meters Biopharma
|
May 25, 2023 | HOLD |
Buy
+3234374900.0% avg upside
11 analysts
|
— | · |
|
SCPX
Scorpius Holdings
|
May 01, 2023 | HOLD |
Strong Buy
+1525941.7% avg upside
11 analysts
|
— | · |
|
BIOCQ
Biocept
|
Jan 06, 2023 | HOLD |
Buy
+42037400.0% avg upside
7 analysts
|
— | · |
|
EDSA
Edesa Biotech
|
Dec 16, 2022 | BUY |
Strong Buy
+56.9% avg upside
6 analysts
|
$13.00
85.26% Upside
|
-21.9% |
|
SCYX
SCYNEXIS
|
Oct 20, 2022 | BUY |
Strong Buy
+180.9% avg upside
10 analysts
|
$8.00
75.18% Upside
|
-25.6% |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.